BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5463059)

  • 1. Lentysine: a new hypolipidemic agent from a mushroom.
    Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T
    Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059
    [No Abstract]   [Full Text] [Related]  

  • 2. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 4. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH; Best MM
    Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 3-hydroxy-3-methylglutaric acid on blood lipids in normal and cholesterol-fed rats.
    Beg ZH; Siddiqi M
    Experientia; 1968 Aug; 24(8):791-2. PubMed ID: 5683167
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of hyperlipidaemic diet and clofibrate treatment on rat erythrocyte lipids.
    Pelliniemi TT; Viikari J; Nieminen L
    Scand J Haematol; 1976 Aug; 17(2):117-22. PubMed ID: 968444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
    Newman HA; Heilman WP; Witiak DT
    Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
    Hashimoto S; Setoyama T; Yokokura T; Mutai M
    Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
    [No Abstract]   [Full Text] [Related]  

  • 11. Appraisal of clofibrate as a hypolipidemic agent.
    Sachs BA
    Am Heart J; 1968 May; 75(5):707-10. PubMed ID: 5645992
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of atromid-S and high fat diet on lipid contents and lipolysis in rat tissues and serum.
    Grafnetter D; Mrhová O; Janda J
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):159-73. PubMed ID: 5551199
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological studies of AT-308. 2. Hypocholesterolemic effect of AT-308, a new derivative of 1,2,4-oxadiazole, in rats.
    Imai Y; Matsumura H; Tamura S; Shimamoto K
    Atherosclerosis; 1973; 17(1):131-7. PubMed ID: 4696739
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
    Guarini G; Costa C; Trimarco C; Santese D; Vitaliano E
    Clin Ter; 1988 Apr; 125(1):41-50. PubMed ID: 2974357
    [No Abstract]   [Full Text] [Related]  

  • 19. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
    Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
    Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.